Yamo Pharma doses first subject in Phase II autism spectrum disorder trial | #autism Clinical Trials Market

News and Politics

Yamo Pharma doses first subject in Phase II autism spectrum disorder trial

The leading companies in the autism clinical trials market are Otsuka Holdings Co Ltd, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, autism Speaks Inc, Johnson & Johnson, Seaside Therapeutics LLC (Inactive), Bristol-Myers Squibb Co, Curemark LLC, Eli Lilly and Co, and F

Robot wars The battle for automated ground capability | #military Unmanned Ground Vehicle Market

News and Politics

Robot wars The battle for automated ground capability

The global military unmanned ground vehicle (UGV) market is valued at $476 million in 2022 and is expected to achieve a CAGR of more than 4% during 2022-2032.

US FDA grants 510K clearance for Aurora Spine’s interbody fusion device | #spinal Fusion devices Market

News and Politics

US FDA grants 510K clearance for Aurora Spine’s interbody fusion device

The Spinal Fusion market size is $7.51 billion in 2021. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, in order to relieve pain.